Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Russom, Mulugetaa; | Tesfai, Dawitb | Solomon Ghebrenegus, Amona; c | Debesai, Merhawia | Kifle, Habtoma; d | Bahta, Iyassue
Affiliations: [a] Eritrean Pharmacovigilance Centre, National Medicines and Food Administration, Asmara, Eritrea | [b] Orotta College of Medicine and Health Sciences, Asmara, Eritrea | [c] Biet-Mekae Community Hospital, Asmara, Eritrea | [d] Department of Public Health, Ministry of Health, Asmara, Eritrea | [e] National Medicines and Food Administration, Asmara, Eritrea
Correspondence: [*] Address for correspondence: Mulugeta Russom, Eritrean Pharmacovigilance Centre, National Medicines and Food Administration, Asmara, Eritrea. Tel.: 00291 7197450; E-mail: [email protected]
Abstract: BACKGROUND:Ranitidine injection is not well-known to cause cardiac arrest except in few published case reports. The Eritrean Pharmacovigilance Centre received four cases of cardiac arrest associated with ranitidine injection. OBJECTIVE:To assess the causal relationship between cardiac arrest and ranitidine, and to identify possible risk factors. METHODS:This is a descriptive case series assessment of cardiac arrest associated with ranitidine and data was mined to supplement the cases from the WHO global database of individual case safety reports. RESULTS:In all cases, ranitidine injection was administered fast IV bolus without proper dilution and the outcome was fatal in three. All patients encountered cardiac arrest within 20 minutes of intravenous use. Causality was found to be probable in two cases and possible in the other two. Cardiac arrest could have been prevented in all cases. On top of this, from the WHO global database, 185 cases of cardiac arrest and cardio-pulmonary arrest associated with ranitidine were retrieved and 49.7% were fatal. In 40% of the cases, ranitidine was reported as a single suspect. In 36 cases, cardiac arrest resolved following withdrawal of ranitidine and reaction recurred in one case after re-introduction of the product. CONCLUSION:There appears a causal link between ranitidine and cardiac arrest, possibly related to medication errors that warrants immediate attention from healthcare professionals.
Keywords: Intravenous ranitidine, administration error, cardiac arrest, WHO global database, healthcare, risk factors
DOI: 10.3233/JRS-200015
Journal: International Journal of Risk & Safety in Medicine, vol. 32, no. 2, pp. 101-107, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]